Report of Foreign Issuer (6-k)
August 03 2017 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the month of August 2017
Commission File Number: 001-36737
NeuroDerm Ltd.
(Translation of registrant’s name
into English)
NeuroDerm Ltd.
Ruhrberg Science Building
3 Pekeris St.
Rehovot 7670212, Israel
+972 (8) 946-2729l
(Address of principal executive office)
Indicate by check mark
whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
¨
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
EXPLANATORY NOTE
On August 3, 2017, NeuroDerm
Ltd. issued a press release, titled “NeuroDerm Announces Second Quarter 2017 Financial Results.” A copy of this press
release is attached to this Form 6-K as Exhibit 99.1.
The information in this
Form 6-K (including in Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it
be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
NeuroDerm Ltd.
|
|
|
|
Date: August 3, 2017
|
By:
|
/s/ Roy Golan
|
|
|
Name: Roy Golan
Title: Chief Financial Officer
|
Exhibit Index
Exhibit
|
|
Description
|
99.1
|
|
Press release dated August 3, 2017, titled “NeuroDerm Announces Second Quarter 2017 Financial Results.”
|
|
|
|
NEURODERM LTD. (NASDAQ:NDRM)
Historical Stock Chart
From Apr 2024 to May 2024
NEURODERM LTD. (NASDAQ:NDRM)
Historical Stock Chart
From May 2023 to May 2024